| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |